Synthesis and evaluation of a new inhibitor of phosphoglucose isomerases: The enediolate analogue 5-phospho-D-arabinohydroxamate

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 23, 1998, Pages 3435-3438

  Hardré, Renaud ^a   Bonnette, Corinne ^a   Salmon, Laurent ^a   Gaudemer, Alain ^a  

^a CNRS   (France)

Author keywords

Carbohydrates; Enzyme inhibitors; Hydroxamic acids; Phosphoric acid and derivs

Indexed keywords

5 PHOSPHOARABINOHYDROXAMATE; ANTIPROTOZOAL AGENT; ENZYME INHIBITOR; GLUCOSE 6 PHOSPHATE ISOMERASE; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; ARTICLE; COMPETITIVE INHIBITION; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SYNTHESIS; ENZYME ACTIVE SITE; ENZYME INHIBITION; PLASMODIUM FALCIPARUM; STRUCTURE ACTIVITY RELATION; TRYPANOSOMA BRUCEI;

EID: 0032403829     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00621-0     Document Type: Article

References (35)

1. 1. Walch, C. In Enzymatic Reaction Mechanisms; Freeman & Co.: San Francisco, 1979; pp. 586-590.
2. 2. Salas, M.; Vinuela, E.; Sols, A. J. Biol. Chem. 1965, 240, 561.
3. 3. Morgan, M. J. FEBS Letters 1981, 130, 124.
4. 4. Merkle, S.; Pretsch, W. Blood 1993, 81, 206.
5. 5. Fillela, X.; Molina, R.; Jo, J.; Mas, E.; Ballesta, A. M. Tumor Biol. 1991, 12, 360.
6. 6. Newton, H. B.; Fleisher, M.; Schwartz, M. K.; Malkin, M. G. Neurology 1991, 41, 395.
7. 7. Watanabe, H.; Takehana, K.; Date, M.; Shinozaki, T.; Raz, A. Cancer Res. 1996, 56, 2960.
8. 8. (a) Verlinde, C. L. M. J.; Witmans, C. J.; Pijning, T.; Kalk, K. H.; Hol, W. G. J.; Callens, M.; Opperdoes, F. R. Protein Science 1992, 1, 1578.
9. (b) Roth, E. F., Jr; Calvin, M.-C.; Max-Audit, I.; Rosa, J.; Rosa, R. Blood 1988, 72, 1922.
10. 9. Fothergill-Gilmore, L. A.; Michels, P. A. M. Prog. Biophys. Molec. Biol. 1993, 59, 105.
11. 10. (a) Shaw, P. J.; Muirhead, H. J. Mol. Biol. 1977, 109, 475.
12. (b) Achari, A.; Marshall, S. E.; Muirhead, H.; Palmieri, R. H.; Noltmann, E. A. Phil. Trans. R. Soc. Lond. B 1981, 293, 145.
13. 11. Schomberg, D.; Salzmann, M. In Enzyme Handbook; Springer-Verlag: Berlin, Heidelberg, 1990.
14. 12. Chirgwin, J. M.; Noltmann, E. A. J. Biol. Chem. 1975, 250, 7272.
15. 13. Parr, C. W. Biochem. J. 1957, 65, 34p.
16. 14. (a) Bruns, F.; Okada, S. Nature 1956, 177, 87.
17. (b) Rose, I. A.; O'Connell, E. L. Biochim. Biophys. Acta 1960, 42, 159.
18. 15. Dyson, J. E. D.; Noltmann, E. A. J. Biol. Chem. 1968, 243, 1401.
19. 16. Shaw, P. J.; Muirhead, H. FEBS Letters 1976, 65, 50.
20. 17. (a) Lewis, D. J.; Lowe, G. J. Chem. Soc. Chem. Comm. 1973, 713.
21. (b) Collins, K. D. J. Biol. Chem. 1974, 249, 136.
22. (c) Davenport, R. C.; Bash, P. A.; Seaton, B. A.; Karplus, M.; Petsko, G. A.; Ringe, D. Biochemistry 1991, 30, 5821.
23. 18. Allen, K. N.; Lavie, A.; Petsko, G. A.; Ringe, D. Biochemistry 1995, 34, 3742.
24. 19. (a) Izquierdo-Martin, M.; Stein, R. L. J. Am. Chem. Soc. 1992, 114, 325.
25. (b) Odake, S.; Okayama, T.; Obata, M.; Morikawa, T.; Hattori, S.; Hori, H.; Nagai, Y. Chem. Pharm. Bull. 1990, 38, 1007.
26. (c) Ikeda-Saito, M.; Shelley, D. A.; Lu, L.; Booth, K. S.; Caughey, W. S.; Kimura, S. J. Biol. Chem. 1991, 266, 3611.
27. (d) Aulabaugh, A.; Schloss, J. V. Biochemistry 1990, 29, 2824.
28. (e) Thomasset, N.; Hamedi-Sangsari, F.; Tournaire, R.; Navarro, C.; Malley, S.; Goetsen, L.; Grange, J.; Vila, J. Int. J. Cancer 1991, 49, 421.
29. 20. Mathis, F. C. R. Hebd. Séances Acad. Sci. 1949, 229, 226.
30. 21. Bonnette, C.; Salmon, L.; Gaudemer, A. Tetrahedron Lett. 1996, 37, 1221.
31. 22. Marchand, M.; Kooystra, U.; Wierenga, R. K.; Lambeir, A.-M.; Van Beeumen, J.; Opperdoes, F. R.; Michels, P. A. M. Eur. J. Biochem. 1989, 184, 455.
32. 23. (a) Noltmann, E. A. J. Biol. Chem. 1964, 239, 1545.
33. (b) Noltmann, E. A. Methods Enzymol. 1966, 9, 557.
34. 24. Kahana, S. E.; Lowry, O. H.; Schulz, D. W.; Passonneau, J. V.; Crawford, E. J. J. Biol. Chem. 1960, 235, 2178.
35. 25. Leriche, C.; Badet-Denisot, M.-A.; Badet, B. J. Am. Chem. Soc. 1996, 118, 1797.